Q

QNRX

QNRX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
QNRX Live QuoteReal-time
$3.28
$0.73(-18.20%)1M
Day Range$3.18 – $3.54
Open$3.31
Previous Close$3.36
Volume11.3K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$16.14M
P/E Ratio (TTM)7.6
Forward P/ENaN
EPS (TTM)$0.44
Price to Book0.6
Dividend Yield0.65%
Beta (Volatility)1.64
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $3.28 (0%)
Low: $3.25High: $23.50
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$20.38-86.4% upside

Insider Buys

1

$280K

Insider Sales

0

$0

Total Volume

$280K

1 transactions

Net Activity

+$280K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

4 Insiders

1 buys0 sells

$280K total

Trading History
QNRX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 31, 2026

2 months ago

Multiple Insiders

4 Insiders

Insider
Buy57.4K$4.88$280K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
QNRX Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

QNRX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for QNRX

Over the last 90 days, corporate insiders at QNRX (QNRX) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $280K.

The net insider activity for QNRX shows a net buying bias of $280K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Multiple Insiders (4 Insiders), who traded 57.4K shares valued at $280K on Aug 31, 2026.

Live Market News & Developments
Aggregated real-time headlines for QNRX (QNRX)
6 updates

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga2h ago

Quoin Pharmaceuticals Stock Price Forecast. Should You Buy QNRX?

StockInvest.us4d ago

QNRX - Quoin Pharmaceuticals Ltd ADR Stock Price and Quote

Finviz177d ago

QNRX Forecast — Price Target — Prediction for 2027

TradingView148d ago

One girl’s skin regenerates 20 to 30 times faster than a peer’s. Her family shares what mornings are like.

Stock Titan14d ago

QNRX Stock Whipsaws As FDA Wins Collide With Rising Losses

timothysykes.com84d ago

FAQs About QNRX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for QNRX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for QNRX is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for QNRX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.